The progestogens vary in their androgenic properties; norethisterone and
7 inert white tablets debossed with a “EV2” on one side and plain on other side
Table 3
Drospirenone, a novel progestin, is structurally similar to spironolactone and acts as an antagonist of aldosterone receptors with an anti-diuretic effect, which may neutralize the RAAS induction caused by estrogen
Brand name
2
Firstly, it reduces estrogen production and lowers PG, vasopressin (VP), and oxytocin levels by inhibiting ovulation
Therefore, COC can be only used with caution or is an absolute contraindication in women with endogenous risk factors COC containing drospirenone (DRSP) is an analog of spironolactone, hence its antimineralocorticoid and antiandrogenic characteristics have been deemed beneficial, although the benefits and/or negative outcome of its usage have not been fully elucidated
The most commonly prescribed pill is the combined hormonal pill with estrogen and progesterone
18 mg) 4 white placebo (inactive) film-coated tablets: If the COC has been taken according to the directions described in section 4
Both hormones work together to prevent pregnancy by: Suppressing ovulation (release of an egg from the ovary) Changing cervical mucus to block sperm
000 users (0,1 %) and declared 2017 that this risk for dienogest containing COC with ethynyl estradiol is still unknown and may be lower than that of other progestogens in combined formulations
Progestin has a few different effects on the female body: Progestational effects: These help prevent ovulation and lessen monthly bleeding
It works by stopping a woman's egg from fully developing each month
If drospirenone and ethinyl estradiol tablets are first taken later than the first day of the menstrual cycle, drospirenone and ethinyl estradiol tablets should not be considered effective as a contraceptive until after the first 7 consecutive days of product Progestogen-only pills (POPs) are a form of oral contraception that is used to prevent pregnancy
Concerns about the tolerability of combined oral contraceptives (COCs) have prompted the development of new oestrogens and progestogens with the